MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation

Cell

Volumn 76, Issue 2, 1994, Pages 287-299

  Germain, Ronald N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ENDOSOME; HUMAN; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0028038426     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(94)90336-0     Document Type: Review

References (83)

1. Antigen presentation by hapten-specific B lymphocytes II Specificity and properties of antigen-presenting B lymphocytes and function of immunoglobulin receptors
2. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules
3. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules
4. Histocompatibility-linked immune response genes
5. Class discrimination in the world of immunology
6. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens
7. Defective major histocompatibility complex class II assembly transport peptide acquisition and CD4+ T cell selection in mice lacking invariant chain expression
8. Structure of the human class I histocompatibility antigen HLA-A2
9. Role for intracellular proteases in the processing and transport of class II HLA antigens
10. Association with BiP and aggregation of class II molecules synthesized in the absence of invariant chain
11. The cell biology of antigen processing and presentation
12. The three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
13. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo
14. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size
15. The protection the unit of humoral immunity selected by evolution
16. Strong and weak histocompatibility gene differences in mice and their role in the rejection of homografts of tumor and skin
17. Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis
18. Intracellular transport and peptide binding properties of HLA class II glycoproteins
19. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes
20. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor
21. Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both β2-microglobulin and peptide
22. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome
23. Delivery of ligands from sorting endosomes to late endosomes occurs by maturation of sorting endosomes
24. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand
25. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
26. Which came first MHC class I or class II?
27. Specificity pockets for the side chains of peptide antigens in HLA-Aw68
28. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes
29. The ins and outs of antigen processing and presentation
30. Seeing double!
31. MHC class II structure occupancy and surface expression determined by post-endoplasmic reticulum antigen binding
32. The biochemistry and cell biology of antigen processing and presentation
33. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes selective cell surface expression of occupied molecules
34. Proteolysis proteosomes and antigen presentation
35. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
36. Promiscuous and allele-specific anchors in HLA-DR-binding peptides
37. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells
38. Characterization of peptides bound to the class I MHC molecule HLA-A21 by mass spectrometry
39. d
40. Regulation of antigen presentation by acidic pH
41. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi
42. The mechanism of antigenic stimulation of primary and secondary clonal precursor cells
43. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages
44. Antigen-specific interaction between T and B cells
45. Invariant chain promotes egress of poorly expressed haplotype-mismatched class II major histocompatibility complex AαAβ dimers from the endoplasmic reticulum/cis-Golgi compartment
46. Intracellular transport of class II MHC molecules directed by invariant chain
47. The three-dimensional structure of HLA-B27 at 21 Å resolution suggests a general mechanism for tight peptide binding to MHC
48. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells
49. Differential activation of T cell clones stimulated by macrophages exposed to antigen complexed with monoclonal antibodies
50. Emerging principles for the recognition of peptide antigens by MHC class I molecules
51. Proteasome subunits encoded in the major histocompatibility complex are not essential for antigen presentation
52. Genes in the MHC that may affect antigen processing
53. Introduction of soluble protein into the class I pathway of antigen processing and presentation
54. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones
55. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter
56. Targeting specific proteins for lysosomal proteolysis
57. Antibody conjugates mimic specific B cell presentation of antigen relationship between T and B cell specificity
58. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments
59. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
60. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class-I molecule
61. Peptide-MHC class II complexes with mixed agonist-antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signalling
62. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides
63. A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA
64. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding
65. Class II MHC molecules are transported to endosomes via the cell surface
66. Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection
67. Relationship between invariant chain expression and MHC class II transport into early and late endocytic compartments
68. Sequence analysis of peptides bound to MHC class II molecules
69. Refined structure of the human histocompatibility antigen HLA-A2 at 26 Å resolution
70. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells
71. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex
72. Acquisition of immunologic self-tolerance
73. Dominance and crypticity of T cell antigenic determinants
74. Capacity of intact proteins to bind to MHC class II molecules
75. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective
76. The dendritic cell system and its role in immunogenicity
77. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways
78. Association of class I major histocompatibility heavy and light chains induced by viral peptides
79. Cytotoxic T cells recognize fragments of the influenza nucleoprotein
80. Signal transduction by receptors with tyrosine kinase activity
81. Mice lacking the MHC class II-associated invariant chain
82. MHC class II-restricted presentation of intracellular antigen
83. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes